MeSH term
Frequency | Condition_Probility | Humans | 61 | 0.0 |
Population Surveillance | 2 | 1.0 |
Animals | 28 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Chromosomes, Human, Pair 4/*genetics | 4 | 4.0 |
Cleft Palate/*genetics/pathology | 3 | 37.0 |
Family Health | 5 | 0.0 |
Female | 31 | 0.0 |
Homeodomain Proteins/*genetics | 20 | 4.0 |
Linkage Disequilibrium | 3 | 0.0 |
Male | 30 | 0.0 |
Microsatellite Repeats | 8 | 0.0 |
Pedigree | 13 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
*Transcription Factors | 23 | 1.0 |
Adolescent | 7 | 0.0 |
Adult | 12 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Anodontia/*genetics | 7 | 38.0 |
Child | 10 | 0.0 |
Child, Preschool | 4 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Genes, Dominant | 7 | 0.0 |
Genes, Homeobox | 5 | 5.0 |
Linkage (Genetics) | 7 | 0.0 |
Middle Aged | 3 | 0.0 |
Odontogenesis/genetics | 2 | 28.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Chile | 5 | 8.0 |
Cleft Lip/*genetics | 11 | 17.0 |
Cleft Palate/*genetics | 10 | 14.0 |
Genetic Markers | 6 | 0.0 |
Linkage Disequilibrium/genetics | 2 | 1.0 |
Monte Carlo Method | 3 | 4.0 |
Transcription Factors/*genetics | 9 | 0.0 |
Alleles | 9 | 0.0 |
Comparative Study | 9 | 0.0 |
Genetic Predisposition to Disease/*genetics | 3 | 0.0 |
Genotype | 16 | 0.0 |
Lod Score | 7 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Genetic Markers/genetics | 3 | 0.0 |
Homeodomain Proteins/genetics | 10 | 4.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
Transforming Growth Factor alpha/genetics | 3 | 11.0 |
Chromosomes, Human, Pair 14/genetics | 2 | 2.0 |
DNA/genetics | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 5 | 0.0 |
Exons/genetics | 3 | 0.0 |
Genes, Dominant/genetics | 2 | 1.0 |
Genetic Heterogeneity | 3 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Phenotype | 10 | 0.0 |
Polymorphism, Genetic/genetics | 4 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Cleft Lip/complications/*genetics | 2 | 40.0 |
Cleft Palate/complications/*genetics | 2 | 40.0 |
*Linkage Disequilibrium | 3 | 1.0 |
Molecular Sequence Data | 13 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Case-Control Studies | 10 | 0.0 |
Chi-Square Distribution | 4 | 0.0 |
Cleft Lip/epidemiology/*genetics | 2 | 25.0 |
Cleft Palate/epidemiology/*genetics | 2 | 25.0 |
Infant | 3 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Logistic Models | 3 | 0.0 |
Maryland/epidemiology | 3 | 23.0 |
Nuclear Family | 2 | 0.0 |
Transforming Growth Factor beta/genetics | 3 | 3.0 |
Genetics, Population | 2 | 0.0 |
Haplotypes/*genetics | 2 | 1.0 |
Introns/genetics | 2 | 0.0 |
Transforming Growth Factor alpha/*genetics | 2 | 4.0 |
Risk Factors | 6 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Cattle | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Chickens | 2 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Heterozygote | 3 | 0.0 |
Mice | 19 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Rats | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Environment | 2 | 2.0 |
Pregnancy | 4 | 0.0 |
Transforming Growth Factor beta/*genetics | 3 | 3.0 |
Base Sequence | 10 | 0.0 |
In Situ Hybridization | 6 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Syndrome | 6 | 0.0 |
Craniofacial Abnormalities/*genetics | 2 | 6.0 |
English Abstract | 3 | 0.0 |
Gene Expression Regulation, Developmental | 5 | 0.0 |
Maxillofacial Development/*genetics | 2 | 66.0 |
Mice, Transgenic | 3 | 0.0 |
Mutation | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 3 | 1.0 |
Gene Expression Regulation | 2 | 0.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
Cell Division | 3 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Gene Expression | 3 | 0.0 |
Time Factors | 2 | 0.0 |
*Trans-Activators | 2 | 0.0 |
DNA-Binding Proteins/genetics | 5 | 0.0 |
Transcription Factors/genetics | 4 | 0.0 |
Binding Sites | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
European Continental Ancestry Group | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics | 2 | 3.0 |
Immunohistochemistry | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
*Chromosomes, Human, Pair 4 | 5 | 2.0 |
European Continental Ancestry Group/genetics | 4 | 0.0 |
Gene Frequency | 4 | 0.0 |
Extremities/embryology | 3 | 8.0 |
Tooth Abnormalities/*genetics | 2 | 18.0 |
Exons | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Genes, Homeobox/genetics | 3 | 10.0 |
Mutation/genetics | 3 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Organ Culture Techniques | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Genes, Homeobox/*genetics | 2 | 3.0 |
Limb Deformities, Congenital/epidemiology/*genetics | 2 | 100.0 |
Philippines | 2 | 6.0 |
Chimera | 2 | 1.0 |
Chromosomes, Human, Pair 4 | 3 | 2.0 |
*Genes, Homeobox | 5 | 2.0 |
Bone Morphogenetic Proteins/genetics/*metabolism | 2 | 11.0 |
Morphogenesis/genetics | 2 | 5.0 |
Finland | 2 | 0.0 |
Cleft Lip/*genetics/pathology | 2 | 28.0 |
Genes, Recessive | 2 | 0.0 |
Anodontia/complications/*genetics | 2 | 100.0 |
Mesoderm/metabolism | 2 | 2.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
